{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-3630", "FDA", "Requests that the FDA issue a declaration permitting the submission of an Abbreviated New Drug Application (ANDA) for Tamsulosin Hydrochloride Capsules, USP 0.8 mg", "Nonrulemaking", "2026-05-14T11:19:06Z", "0b000064b924c542"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-3630"], "units": {}, "query_ms": 0.39709790144115686, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}